These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2260030)

  • 1. [Financial analysis of hospitalizations for adverse effects of drugs. The economic role of the Regional Pharmacovigilance Center].
    Mignot G; Biaggi J; Lethurgez P; Chichmanian RM
    Therapie; 1990; 45(5):387-90. PubMed ID: 2260030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of ten years of pharmacovigilance of antihypertensive drugs in the Toulouse University Regional Hospital Center (1981-1990)].
    Jacquet A; Sorbette F; Montastruc JL
    Therapie; 1993; 48(2):141-4. PubMed ID: 8351683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychic effects of drugs prescribed for hypertensive patients. An experiment of the Regional Drug Monitoring Center in Marseilles].
    Jouglard J; Poyen B; Rodor F; Galland MC; Jean P; Thomas A
    Therapie; 1990; 45(1):37-41. PubMed ID: 2343434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost of hospitalizations for adverse drug effects].
    Detournay B; Fagnani F; Pouyanne P; Haramburu F; Begaud B; Welsch M; Imbs JL
    Therapie; 2000; 55(1):137-9. PubMed ID: 10860015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Users of a regional center of pharmacovigilance].
    Haramburu F; Abraham E; Bégaud B
    Therapie; 1993; 48(5):475-7. PubMed ID: 8146828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A 30-month study of the calls to the Regional Drug Monitoring Center in Lorraine (Nancy)].
    Trechot PF; Royer RJ; Gaire M; Gaspard MC; Netter P
    Therapie; 1990; 45(1):43-6. PubMed ID: 2343435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inventory of questions posed at a Regional Pharmacovigilance Center. Discussion about a possible coordination of informatics].
    Carlier P; Lagier G; Castot A; Bidault I
    Therapie; 1990; 45(5):383-6. PubMed ID: 2260029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Organization and results of drug vigilance in France].
    Bégaud B; Chaslerie A; Haramburu F
    Rev Epidemiol Sante Publique; 1994; 42(5):416-23. PubMed ID: 7973001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of unexpected and toxic effects of omeprazole (Mopral) reported to the regional centers of pharmacovigilance during the first 22 postmarketing months].
    Castot A; Bidault I; Dahan R; Efthymiou ML
    Therapie; 1993; 48(5):469-74. PubMed ID: 8146827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amineptin abuse. Analysis of 155 cases. An evaluation of the official cooperative survey of the Regional Centers of Pharmacovigilance].
    Castot A; Benzaken C; Wagniart F; Efthymiou ML
    Therapie; 1990; 45(5):399-405. PubMed ID: 2260032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacovigilance of antibiotics. Evaluation by the Midi-Pyrénées Pharmacovigilance Center between 1989 and 1992].
    Llau ME; Damase-Michel C; Lapeyre-Mestre M; Vie M; Rascol O
    Therapie; 1994; 49(2):123-7. PubMed ID: 7817335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of pharmacovigilance center in information for the public on drugs. Experience in Marseille on 9 month].
    Jean-Pastor MJ; Morange-Sala S; Rodor F; Gambini D; Galland MC; David JM; Jouglard J
    Therapie; 1992; 47(5):429-32. PubMed ID: 1299984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacovigilance of self-medication].
    Montastruc JL; Bagheri H; Geraud T; Lapeyre-Mestre M
    Therapie; 1997; 52(2):105-10. PubMed ID: 9231503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Direct reporting of side effects by the patient: favourable experience in the first year].
    van Grootheest AC; Passier JL; van Puijenbroek EP
    Ned Tijdschr Geneeskd; 2005 Mar; 149(10):529-33. PubMed ID: 15782689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacovigilance as new direction of research].
    Gaszner G; Makkos Z; Gaszner P
    Neuropsychopharmacol Hung; 2005 Dec; 7(4):194-8. PubMed ID: 16496484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Joint program of pharmacovigilance in Quebec: comparison with France, Aquitaine and the Basque region].
    Biron P; Balency D
    Therapie; 1996; 51(5):578-81. PubMed ID: 9138400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A one-year prospective and intensive pharmacovigilance of antilipemic drugs in an hospital consultation for prevention of risk factors].
    Jacquet A; Colomes M; Ferrieres J; Denat M; Douste-Blazy P; Monstastruc JL
    Therapie; 1993; 48(5):509-12. PubMed ID: 8146847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced dementia: a case/non-case study in the French Pharmacovigilance database].
    Favrelière S; Lafay-Chebassier C; Alkhidir F; Merlet I; Pérault Pochat MC
    Therapie; 2007; 62(6):507-11. PubMed ID: 18316017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug vigilance: opinion survey among residents of a university hospital].
    Graille V; Lapeyre-Mestre M; Montastruc JL
    Therapie; 1994; 49(5):451-4. PubMed ID: 7855763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.